Impact of body mass index and visceral adiposity on outcomes in colorectal cancer

Asia-Pacific Journal of Clinical Oncology

Volumn 8, Issue 4, 2012, Pages 337-345

  Yamamoto, Naoto ^a   Fujii, Shoichi ^b   Sato, Tsutomu ^b   Oshima, Takashi ^b   Rino, Yasushi ^c   Kunisaki, Chikara ^b   Masuda, Munetaka ^c   Imada, Toshio ^d  

^a KANAGAWA CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Colorectal cancer; Obesity; Prognosis; Recurrence; Visceral adiposity

Indexed keywords

AGED; ARTICLE; BODY MASS; CANCER SURVIVAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SUBCUTANEOUS FAT; VISCERAL OBESITY;

ADIPOSITY; AGED; BODY MASS INDEX; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; OBESITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84870318763     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2011.01512.x     Document Type: Article

References (49)

1. Yamashita S, Nakamura T, Shimomura I etal. Insulin resistance and body fat distribution. Diabetes Care 1996; 19: 287-91.
2. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004; 23: 6365-78.
3. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3: 565-74.
4. Gendall KA, Raniga S, Kennedy R, Frizelle FA. The impact of obesity on outcome after major colorectal surgery. Dis Colon Rectum 2007; 50: 2223-37.
5. Gorog D, Nagy P, Peter A, Perner F. Influence of obesity on lymph node recovery from rectal resection specimens. Pathol Oncol Res 2003; 9: 180-3.
6. Leroy J, Ananian P, Rubino F, Claudon B, Mutter D, Marescaux J. The impact of obesity on technical feasibility and postoperative outcomes of laparoscopic left colectomy. Ann Surg 2005; 241: 69-76.
7. Marks JH, Kawun UB, Hamdan W, Marks G. Redefining contraindications to laparoscopic colorectal resection for high-risk patients. Surg Endosc 2008; 22: 1899-904.
8. Schwandner O, Farke S, Schiedeck TH, Bruch HP. Laparoscopic colorectal surgery in obese and nonobese patients: do differences in body mass indices lead to different outcomes? Surg Endosc 2004; 18: 1452-6.
9. Tsukada K, Miyazaki T, Kato H etal. Body fat accumulation and postoperative complications after abdominal surgery. Am Surg 2004; 70: 347-51.
10. Pikarsky AJ, Saida Y, Yamaguchi T etal. Is obesity a high-risk factor for laparoscopic colorectal surgery? Surg Endosc 2002; 16: 855-8.
11. Senagore AJ, Delaney CP, Madboulay K, Brady KM, Fazio VW. Laparoscopic colectomy in obese and nonobese patients. J Gastrointest Surg 2003; 7: 558-61.
12. Seki Y, Ohue M, Sekimoto M etal. Evaluation of the technical difficulty performing laparoscopic resection of a rectosigmoid carcinoma: visceral fat reflects technical difficulty more accurately than body mass index. Surg Endosc 2007; 21: 929-34.
13. Tsujinaka S, Konishi F, Kawamura YJ etal. Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum 2008; 51: 1757-65; discussion 65-7.
14. Gutierrez DA, Puglisi MJ, Hasty AH. Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Curr Diab Rep 2009; 9: 26-32.
15. Shah A, Mehta N, Reilly MP. Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr 2008; 32: 638-44.
16. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-83.
17. McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 2003; 90: 215-9.
18. McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007; 22: 881-6.
19. Malik HZ, Prasad KR, Halazun KJ etal. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007; 246: 806-14.
20. Yoshizumi T, Nakamura T, Yamane M etal. Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283-6.
21. World Health Organization. BMI classification. [Cited 7 July 2011]. Available from: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
22. Examination Committee of Criteria for "Obesity Disease" in Japan; Japan Society for the Study of Obesity. New criteria for "obesity disease" in Japan. Circ J 2002; 66: 987-92.
23. Kunisaki C, Makino H, Yamamoto N etal. Learning curve for laparoscopy-assisted distal gastrectomy with regional lymph node dissection for early gastric cancer. Surg Laparosc Endosc Percutan Tech 2008; 18: 236-41.
24. Oka R, Kobayashi J, Yagi K etal. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 2008; 79: 474-81.
25. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-4.
26. Halazun KJ, Aldoori A, Malik HZ etal. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008; 34: 55-60.
27. Sobin LH, Wittekind C (eds). TNM Classification of Malignant Tumors, 6th edn. Wiley-Liss, Inc, New York 2002.
28. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 2009; 16: 614-22.
29. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int J Obes 1983; 7: 437-45.
30. Kvist H, Chowdhury B, Sjostrom L, Tylen U, Cederblad A. Adipose tissue volume determination in males by computed tomography and 40K. Int J Obes 1988; 12: 249-66.
31. Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006; 38: 52-63.
32. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7.
33. Jacobs ET, Ahnen DJ, Ashbeck EL etal. Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 2009; 169: 657-66.
34. McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Williston Park) 2005; 19: 871-81; discussion 81-2, 85-6.
35. Pischon T, Lahmann PH, Boeing H etal. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006; 98: 920-31.
36. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131: 3109S-20S.
37. Hu FB, Manson JE, Liu S etal. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-7.
38. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002; 94: 972-80.
39. Stattin P, Lukanova A, Biessy C etal. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004; 109: 149-52.
40. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005; 97: 1688-94.
41. Sugiyama M, Takahashi H, Hosono K etal. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 2009; 34: 339-44.
42. Yoneda K, Tomimoto A, Endo H etal. Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol Rep 2008; 20: 479-83.
43. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 2007; 246: 1047-51.
44. Dignam JJ, Polite BN, Yothers G etal. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006; 98: 1647-54.
45. Haydon AM, Macinnis RJ, English DR, Giles GG. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 2006; 55: 62-7.
46. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-38.
47. Meyerhardt JA, Catalano PJ, Haller DG etal. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003; 98: 484-95.
48. Moon HG, Ju YT, Jeong CY etal. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 2008; 15: 1918-22.
49. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 2007; 31: 500-6.